These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 14237159)

  • 1. A STUDY OF SABIN TYPE 1 ORAL VACCINE VIRUS DURING FIVE HUMAN PASSAGES.
    PAVILANIS V; LUSSIER G; FOLEY AR; CHARBONNEAU JH; DIFRANCO E; DUBREUIL R
    Rev Can Biol; 1964 Sep; 23():265-76. PubMed ID: 14237159
    [No Abstract]   [Full Text] [Related]  

  • 2. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
    FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
    Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
    [No Abstract]   [Full Text] [Related]  

  • 3. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 4. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 5. [EVALUATION OF NEURAL LESIONS IN MONKEYS INOCULATED WITH SABIN POLIOVIRUS VACCINE].
    LUSSIER G; PAVILANIS V; DIFRANCO E
    Rev Can Biol; 1964 Sep; 23():323-32. PubMed ID: 14237165
    [No Abstract]   [Full Text] [Related]  

  • 6. CHARACTERISTICS OF SABIN TYPE 1 POLIOVIRUS AFTER GASTROINTESTINAL PASSAGE IN NEWBORN INFANTS. II. ANTIGENICITY AND ELUTION FROM AL(OH)3 GEL.
    WOODS WA; ROBBINS FC; WEISS RA; CASHEL J; KIRSCHSTEIN RL
    Am J Hyg; 1964 Mar; 79():236-44. PubMed ID: 14131876
    [No Abstract]   [Full Text] [Related]  

  • 7. PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS.
    SIMON J
    Arch Gesamte Virusforsch; 1965; 15():220-33. PubMed ID: 14269256
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON THE EFFECT OF DEXTRAN SULFATE ON SABIN ORAL POLIOMYELITIS VACCINAL STRAINS].
    VOSS H
    Z Naturforsch B; 1964 Mar; 19():226-9. PubMed ID: 14175997
    [No Abstract]   [Full Text] [Related]  

  • 9. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.
    VONKA V; JANDA Z; SIMON J
    Arch Gesamte Virusforsch; 1964 Jun; 14():599-610. PubMed ID: 14247356
    [No Abstract]   [Full Text] [Related]  

  • 10. MARKER TEST OF POLIOVIRUS IN RELATION TO MASS VACCINATION WITH LIVE ORAL VACCINES.
    TOYOSHIMA K; MITSUDA B; TADOKORO J; YAMADA T; KUNITA N
    Biken J; 1963 Jul; 6():57-72. PubMed ID: 14147706
    [No Abstract]   [Full Text] [Related]  

  • 11. RESULTS OF INVESTIGATION OF TYPE 1 VIRUSES ISOLATED FROM PARALYTIC PATIENTS IN THE PERIOD FOLLOWING MASS VACCINATION WITH SABIN'S VACCINE IN CZECHOSLOVAKIA IN 1960.
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():58-76. PubMed ID: 14128980
    [No Abstract]   [Full Text] [Related]  

  • 12. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE NEUROVIRULENCE TEST OF LIVE POLIOVIRUS VACCINES. I. BASES, TECHNIC AND EVALUATION OF THE RESEARCH ON NEUROVIRULENCE MEASUREMENT IN MONKEYS].
    BONIN O; UNTERHARNSCHEIDT F
    Arch Psychiatr Nervenkr; 1964 Nov; 206():260-71. PubMed ID: 14344120
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES].
    UNTERHARNSCHEIDT F; BONIN O
    Arch Psychiatr Nervenkr; 1965 Mar; 206():454-73. PubMed ID: 14271779
    [No Abstract]   [Full Text] [Related]  

  • 15. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
    J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EXPERIENCE IN THE ADMINISTRATION OF LIVE ATTENUATED POLIOVIRUS VACCINE (SABIN) IN INFANTS, WITH REFERENCE TO THE RELATION BETWEEN POLIO AND NON-POLIO VIRUSES.
    KONISHI S; SASATANI M; HAYAKAWA Y; KUROSE T; ASHIHARA Y
    Shonika Kiyo; 1963; 9():283-96. PubMed ID: 14112921
    [No Abstract]   [Full Text] [Related]  

  • 17. [BEHAVIOR OF AN ATTENUATED LSC 2 AB STRAIN OF POLIOMYELITIS VIRUS TYPE I FOLLOWING FRACTIONATION ON SOME ION-EXCHANGERS].
    ZALMANZON ES; LOBAREVA LS
    Vopr Virusol; 1964; 42():559-64. PubMed ID: 14256618
    [No Abstract]   [Full Text] [Related]  

  • 18. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 19. NEUROVIRULENCE FOR MONKEYS OF SABIN'S TYPE 1 POLIOVIRUS PASSED THROUGH HUMAN INTESTINES AS COMPARED WITH ATTENUATED AND VIRULENT POLIOVIRUS STRAINS.
    SIMON J
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():506-15. PubMed ID: 14238949
    [No Abstract]   [Full Text] [Related]  

  • 20. [THE VALUE OF GENETIC MARKERS OF THE POLIOVIRUS FOR THE EVALUATION OF SUPPOSED INCIDENTS FOLLOWING ORAL VACCINATION].
    POETSCH F
    Zentralbl Bakteriol Orig; 1963 Dec; 191():112-6. PubMed ID: 14119890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.